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Type d'étude : rétrospective observationnelle
Patients : 288 patients opérés de chirurgie urologique associée à une DPOP. plays an important role in reducing the risk of PPSP (13) . The absence of such recommendations after urology surgery is probably due to the lack of data. Therefore, our objective was to assess the incidence of PPSP, its characteristics (i.e neuropathic pain) and the its associated risk factors following urology surgery. We assessed pre, intra and postoperative factors and evaluated their relationship with PPSP. 
Méthodes

Methods
Patients
Data collection
The following data were recorded: age, sex, type of surgery, type of anesthesia, pain preexisting the surgery, pre-, intra-and postoperative pain medication, morphine consumption 48 hours after the surgery, time between surgery and questionnaire administration. At the time of the questionnaire, the type of pain, the pain score (numerical rating scale from 0 to 10, where 0 = no pain and 10 = worst pain imaginable), and the use of pain medication were also collected. Neuropathic pain was defined using the DN4 "7 items" score (14) . A DN4 score higher than 3 (on 7 items) was considered as positive for neuropathic pain. Pain preexisting the surgery was defined as pain of any type associated or not with the condition requiring surgery. In addition to the 7 items, the effect of "brushing", which is part of the original complete DN4 questionnaire (10 items), was included as an 8 th item.
PPSP was considered present when the patient reported pain with a NRS of 3 or higher, in the area of the surgery.
Statistical analysis
Statistical analysis was performed with SAS software 8.02 (SAS Institute, Cary, N.C., USA). Less than 8 % (n = 22) of the patients had preoperative pain. PPSP, assessed approximately from 3 to 11 months after the surgery, was reported by 24 % (n = 70) of the patients.
Very few patients answered the 8 th item of the questionnaire. This did not allow any statistics.
Patients with PPSP
Among the 70 (24 %) patients describing PPSP, 30 (43 %) had sleep disturbance and 34 (49 %) used pain medication (Table 1) . Twenty-five (36%) of them reported neuropathic pain (DN4 ≥3). The worst pain experienced within the week prior the questionnaire was higher than 5 on a 10-point scale in 28 (40 %) patients with PPSP.
Predictive factors of PPSP in univariate analysis
Preoperative pain, and postoperative morphine consumption were significantly associated with an increased risk of PPSP, whereas patients who received postoperative nonsteroidal anti-inflammatory drugs reported significantly less PPSP ( Table 2 ). The global mean morphine consumption 48 hours after surgery was 13 ± 19 mg. In patients without PPSP, it was 10 ± 15 mg and this consumption doubled in patients reporting PPSP (22 ± 26 mg). The patients who received a preperitoneal continuous infiltration significantly undergone more procedures classified as high risk and their consumption of postoperative morphine was significantly higher (p = 0.016).
Predictive factors of PPSP in multivariate analysis
Multivariate logistic regression analysis identified two independent risk factors of developing PPSP: preoperative pain (OR = 21.6, 95% CI 6.7-69.5, p < 0.0001) and morphine consumption 48 hours after surgery higher than 6 mg (OR = 2.3, 95% CI 1.2-4.3, p = 0.012).
Discussion
In this study, 24% of the patients reported PPSP after urology surgery. Amongst them, 36 % reported neuropathic pain. The two independent risk factors associated with PPSP following urology surgery were: preoperative pain and postoperative morphine consumption.
The prevalence of PPSP of 24% 3 to 11 months after urology surgery is comparable with other studies. Recently published incidences vary between 14% 3 months after prostatectomy (16) and 26 to 28% 3 months after nephrectomy (17, 18) . In most previous studies the distinction between neuropathic and nociceptive pain was not described. The recent Tromso study reported an incidence of 24.5 % of sensory abnormalities after various type of surgery. This was strongly associated with PPSP (19) . In our study, PPSP was classified as neuropathic pain in 36 % of the cases. This is higher than the 14 % of neuropathic PPSP after nephrectomy reported by Owen et al (17) . However, our results were not specifically focused on nephrectomy but on various urological surgeries.
Preoperative pain was the strongest independent risk factor with an odds ratio of 21.6 (95% CI 6.7-69.5). Recent reviews have described preoperative pain as being a typical risk factor of PPSP (4) . Some studies have indeed reported a link between preoperative pain and PPSP after amputation (20) , hernia repair (21), hysterectomy (10, 22) and thoracotomy (23) . Some studies did not report a statistically significant link especially after thoracotomy (7). Indeed, the authors of a systematic review published in 2009 were not able to draw a conclusion because of the inconsistencies of the data (24) . These discrepancies could be due to interindividual variability described by some authors (25) . Our results showed a strong link and add more data into this field. The likelihood of PPSP in patients with preoperative pain was so high in our study that it called for establishing specific clinical perioperative pathways in these patients.
In our study, morphine consumption higher than 6 mg 48 hours after the surgery was also associated with an increased risk of PPSP. Opioid-induced hyperalgesia had been first described with remifentanil (26) . Since this article, it has also been identified with fentanyl and with morphine. Chronic use of opioid can also increase the risk of hyperalgesia (27) .
Within the perioperative context, a study showed that opioid-induced hyperalgesia with a high dose of remifentanil was associated with a higher incidence of PPSP after thoracotomy (28) . Preventing hyperalgesia (inflammation-induced and opioid-induced hyperalgesia) can prevent post surgical pain 6 months to one year after surgery (29) . This was shown with ketamine or epidural (29, 30) . Overall, it seems that preventing high opioid consumption would prevent opioid-induced hyperalgesia and PPSP. However, high postoperative morphine consumption is always associated with intense acute postoperative pain. Indeed, acute postoperative pain per se has also been linked with the risk of PPSP (31) even in patients who did not receive any morphine (12) . The need for additional clinical studies on surgical-induced and opioid-induced hyperalgesia was recently underlined (32) . Therefore our study brings more evidence in confirming the hypothesis that opioid consumption including postoperative morphine consumption is linked to the risk of PPSP.
No other data were significantly associated with the risk of PPSP in our study. In particular, perioperative administrations of ketamine, gabapentine or pregabaline were not protective against PPSP. Only a very small fraction of the patients received gabapentinoids. However, the most recent meta analysis on the subject did not suggest any reduction in chronic pain with gabapentinoids (33) . Ketamine was often administered (57%) in our study but the administration was only very rarely continued after the end of surgery. The most recent meta analysis reported that ketamine could reduce PPSP 3 months after surgery if the administration was prolonged for 24 hours (33). This could explain our negative results.
Our study has several limitations. It is an observational study that did not include the elements of the ideal study design of PPSP as defined by Kehlet et al. (34) . The minimum of three months period was chosen according to the literature. Although the IASP-published definition several years ago was 2 months (35), some authors have proposed 3 months (34).
In our study, the mean time between surgery and completing the questionnaire was 201 days with a wide range (92-336). However, this elapsed survey period was statistically similar between the two groups. Our study was neither randomized nor controlled and the patients who received a local anesthetics infiltration significantly undergone more procedures classified as high risk and their consumption of postoperative morphine was significantly higher. This was not the case for ketamine or gabapentinoids administration. Finally, we did not record the preoperative morphine consumption, which could influence the postoperative consumption.
In conclusion, our study confirmed that preoperative pain and morphine consumption are strong risk factors of PPSP after urology surgery. These findings bring evidences in the role of preoperative pain and morphine consumption in the genesis of PPSP and could suggest the need to establish clinical perioperative pathways tailored to the patient.
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